SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is seeing heightened activity as community members debate whether the asset is entering a fresh breakout phase fueled by industrial demand for chip production and potential supply chain constraints. Traders are closely tracking volatility in the silver-to-gold ratio and futures markets, with active discussions focused on whether the current momentum represents a sustainable bull run or a continuation of historical cycles of sharp, volatility-driven price swings.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors aggressively bid up the stock amid an AI-driven memory chip shortage, with community sentiment heavily focused on potential valuation reratings and record-breaking earnings growth. While retail traders express extreme optimism over supply bottlenecks and Wall Street price target hikes, some community voices remain cautious about bubble risks and volatility surrounding the semiconductor supercycle.

Odysight.ai, Inc. engages in the development and manufacture of customized visual solutions for organizations across a variety of industries in the form of micro cameras and supplementary technologies. Its devices can used across the medical, aerospace, industrial, research, and defense industries. The company was founded on March 22, 2013 and is headquartered in Omer, Israel.

Odysight.ai Inc

Odysight.AI Inc

Odysight.AI is generating significant trading activity driven by a new Cooperative Research and Development Agreement with the U.S. Navy for AI-driven visual sensing technology. While some community members are optimistic about the potential for a momentum squeeze and defense sector growth, others are expressing skepticism regarding the company's long-term commercial execution and historical financial performance.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing heightened volatility and increased trading volume as the market reacts to early-stage research into an mRNA-based Hantavirus vaccine following a recent cruise ship outbreak. While some retail investors are treating the stock as a pandemic-era play reminiscent of 2020, others are closely monitoring technical indicators and biotech sector rotations, with the community actively debating whether the headlines represent a sustainable catalyst or temporary sentiment-driven hype.

Xiao-I Corp. is a holding company, which engages in Internet technology development through its subsidiaries. It focuses on business solutions and services in artificial intelligence, covering natural language processing, voice and image recognition, machine learning, and affective computing. The company was founded in 2001 and is headquartered in Shanghai, China.

Xiao-I Corp - ADR

XIAO-I Corporation

XIAO-I Corporation is trending as investors weigh the impact of a forthcoming 1-for-20 reverse stock split against ongoing speculative hopes for a significant legal settlement with Apple. While some community members anticipate a potential short squeeze due to the reduced float and high short interest, others are warning of historical patterns of dilution often associated with small-cap ADR restructurings.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense volatility as investors weigh the potential of its strategic partnership with Nvidia against concerns over immediate share dilution from a major convertible notes offering. The community remains sharply divided between long-term bulls betting on the company's AI infrastructure buildout and skeptics wary of persistent capital raises and the stock's recent rapid appreciation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting a positive final pre-BLA meeting with the FDA, which solidified the development path for sonelokimab in hidradenitis suppurativa. The community is actively discussing the stock's long-term potential, with bullish sentiment focusing on the upcoming Phase 3 data readouts and best-in-class label expectations, while some participants remain cautious due to recent range-bound price action and the risks inherent in clinical-stage biotech.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is rallying after a strong earnings beat, with investors buoyed by revenue growth, raised guidance, and signs of success in its AI platform adoption. While the community is actively debating whether the stock is undervalued and primed for a squeeze, many are highlighting the company's solid balance sheet and cash flow as key pillars for its recovery.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is experiencing significant volatility and trading volume as investors react to a scheduled 1-for-20 reverse stock split. The community remains deeply divided, with some traders targeting a potential squeeze driven by a reduced float, while others warn of a persistent pattern of dilution and repeat splits that have historically eroded shareholder value.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as investors monitor silver's price action alongside upcoming earnings, with the community actively debating whether current support levels represent a final dip or a prelude to further downside. Discussion remains heavily focused on the stock's torque to silver prices, supply chain constraints in the mining sector, and the potential for a momentum breakout once macroeconomic uncertainty stabilizes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
